From The Stage

WRIB

Posted by BioAgilytix / /

EBF

Posted by BioAgilytix / /

For the 8th Time, BioAgilytix Named to Inc. 5000 Annual List of America’s Fastest-Growing Private Companies

Posted by BioAgilytix / /

Ranked No. 1939, With 3-Year Revenue Growth of 230 Percent DURHAM, NC, August 25, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, was recently ranked number 1939 on Inc.’s annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy, and 2021 marks BioAgilytix’s eighth appearance on the list since 2013. The annual list recognizes…

[EPISODE 12] Dr. Jennifer Zemo talks mentorship, kinase proteins and customer service!

Posted by BioAgilytix / /

On this episode of Molecular Moments, Chad Briscoe chats with Dr. Jennifer Zemo, Director, Bioanalytical Operations at BioAgilytix. She’s a great leader, mentor and scientist with a love for helping people and the sciences. They discuss her start as a chemistry major in college, which led to her Ph.D. in Biological Chemistry and eventually to joining BioAgilytix 8 years ago. A large molecule expert, Jennifer shares how she went from pharma to CRO, the importance of customer service and the ability to be creative in assay development.They also discuss how…

MicroConstants to Join BioAgilytix Family

Posted by BioAgilytix / /

Highly complementary transaction strengthens BioAgilytix’s ability to support bioanalytical services across all major therapeutics in development; adds LC/MS/MS capabilities; and expands team of seasoned scientistsDurham, NC, August 18, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed a definitive agreement to acquire MicroConstants, adding it to its family of companies.MicroConstants, to be known as BioAgilytix San Diego, provides industry-leading services in method development, validation, and sample…

BioAgilytix to Purchase Australia-based 360biolabs®

Posted by BioAgilytix / /

Highly complementary transaction will strengthen company’s ability to support bioanalytical services across all stages, development capabilities and geographiesDurham, NC, August 16, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed a definitive agreement to purchase 360biolabs®, the most comprehensive contract research organization in Australia. The transaction will expand BioAgilytix’s global footprint into a jurisdiction of choice to commence first-in-human trials (FIH) and early-phase clinical trials and adds further capacity by…